Senti Biosciences Holdings, Inc. SEC filings SNTI

Senti Biosciences Holdings, Inc. has 367 filings in SEC EDGAR's recent list, going back to Apr 2, 2021. Its latest annual report, Form ARS, was filed on Jul 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jul 21, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders May 29, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 21, 2024 Dec 31, 2023
ARS Annual report to shareholders May 1, 2023 Apr 28, 2023
10-K Annual report Mar 22, 2023 Dec 31, 2022
10-K Annual report Mar 7, 2022 Dec 31, 2021

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SNTI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
, Emerging growth company
SEC CIK
1854270
Former names
Senti Biosciences, Inc. (until May 8, 2026); Senti Biosciences, Inc.\ (until Jun 28, 2022); Dynamics Special Purpose Corp. (until Jun 13, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.